Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
复制标题
DOI：
10.1007/s10147-019-01485-z
复制
发表时间：
2020-01-01
影响因子：
3.3
通讯作者：
Sugihara, Kenichi
中科院分区：
文献类型：
--
作者：
Hashiguchi, Yojiro;Muro, Kei;Sugihara, Kenichi
日本死于结直肠癌的人数继续增加。2016年，结直肠癌死亡人数超过5万人。在2019年版中，对治疗的所有方面进行了修订，并根据自2016年版(药物治疗)和2014年版(其他治疗)以来获得的知识进行了更正和补充。日本结直肠癌治疗协会2019年结直肠癌治疗指南(JSCCR 2019年指南)已经准备好展示结直肠癌的标准治疗策略，消除机构之间在治疗方面的差异，消除不必要的治疗和治疗不足，并通过向公众提供这些指南来加深医护人员和患者之间的相互了解。这些指南是根据JSCCR指南委员会达成的共识，基于对通过文献搜索检索的证据的仔细审查，并考虑到日本的医疗健康保险制度和实际临床实践环境而制定的。因此，这些指南可以在实际的临床实践中用作治疗结直肠癌的工具。更具体地说，它们可以作为获得患者知情同意和为每个患者选择治疗方法的指南。有争议的问题被选为临床问题，并提出了建议。每项建议都附有证据分类和根据准则委员会成员达成的协商一致意见对建议类别进行分类。在这里，我们介绍JSCCR 2019年指南的英文版。
The number of deaths from colorectal cancer in Japan continues to increase. Colorectal cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of treatments was performed, with corrections and additions made based on knowledge acquired since the 2016 version (drug therapy) and the 2014 version (other treatments). The Japanese Society for Cancer of the Colon and Rectum guidelines 2019 for the treatment of colorectal cancer (JSCCR guidelines 2019) have been prepared to show standard treatment strategies for colorectal cancer, to eliminate disparities among institutions in terms of treatment, to eliminate unnecessary treatment and insufficient treatment and to deepen mutual understanding between healthcare professionals and patients by making these guidelines available to the general public. These guidelines have been prepared by consensuses reached by the JSCCR Guideline Committee, based on a careful review of the evidence retrieved by literature searches and in view of the medical health insurance system and actual clinical practice settings in Japan. Therefore, these guidelines can be used as a tool for treating colorectal cancer in actual clinical practice settings. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. Controversial issues were selected as clinical questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories based on the consensus reached by the Guideline Committee members. Here, we present the English version of the JSCCR guidelines 2019.